Validation and Standardisation of a Pool of Simplified Evaluation Aimed to the Diagnoses of Aphasic Disorders and Adapted to the Patients Suffering an Acute Phase of Stroke (BESTA-AVC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02548481|
Recruitment Status : Recruiting
First Posted : September 14, 2015
Last Update Posted : August 17, 2016
Every year in France, from 100 000 to 145 000 people are affected by a stroke. 75% patients survived with aftereffects, in particular aphasic disorders.
A sketch of a new tool called BESTA aiming to a rapid handover to the acute phase post stroke had been worked out. After a meeting, 13 multidisciplinary experts have discussed, adjusted and a new complete tool (BESTA) had been created in order to evaluate the different states of aphasia.
The goal of this study is the validation and the standardization of this new BESTA tool.
|Condition or disease||Intervention/treatment|
|Stroke||Other: BESTA scale|
|Study Type :||Observational|
|Estimated Enrollment :||395 participants|
|Official Title:||Validation and Standardisation of a Pool of Simplified Evaluation Aimed to the Diagnoses of Aphasic Disorders and Adapted to the Patients Suffering an Acute Phase of Stroke|
|Study Start Date :||November 2015|
|Estimated Primary Completion Date :||August 2018|
|Estimated Study Completion Date :||January 2019|
BESTA scale is administered at T0, T1 (3 months) and T2 (1 year)
Other: BESTA scale
BESTA scale is administrated at T0, T1 and T2.
- validity of concomitant criterion at T0 versus LAST [ Time Frame: 1 day ]
T0: the gold standard was determined by the expert group is the LAST screening tool.
The tool to be evaluated is the BESTA at T0. However, as written expression is not evaluated in the LAST, only the dimensions and Oral Expression Listening Comprehension of BESTA may actually be faced with LAST scale.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02548481
|Contact: Amandine CHANAUD||+33 555 05 88 firstname.lastname@example.org|
|Limoges, France, 87 042|
|Contact: Francisco MACIAN, MD|
|Principal Investigator:||Francisco MACIAN, MD||University Hospital, Limoges|